Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Moxetumomab Pasudotox-tdfk
Determining the interaction of Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxetumomab pasudotox-tdfk Intravenous
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxifloxacin
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxifloxacin (Systemic)
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxifloxacin Hydrochloride
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxifloxacin Injection
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Kitabis Pak
- Moxetumomab Pasudotox-tdfk-Kitabis Pak inhalation
- Moxetumomab Pasudotox-tdfk-Klofensaid II
- Moxetumomab Pasudotox-tdfk-Klonopin
- Moxetumomab Pasudotox-tdfk-Klonopin Wafer
- Moxetumomab Pasudotox-tdfk-Klonopin Wafers